Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-23

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM from Torrent Pharmaceuticals Limited, enabling a generic version of the anti-seizure medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)